Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by BuddingInvestoron Jan 02, 2019 5:04pm
110 Views
Post# 29179056

RE:HOW WILL CANOPY, TILRAY , CRONOS SURVIVE???

RE:HOW WILL CANOPY, TILRAY , CRONOS SURVIVE???The answer to your question is economies of scale. It takes a long time to build global giants. I believe Canopy is going to show how profitable it's Canadian operations are in the near future. Creating a global giant costs money. It's also why aph lost its streak of positive quarters. It's all good. I'd rather Aphria sacrifice profitability now for greater reward in the future.
canucks444 wrote: Investigator said....." "The math on this is simple. The company will have production capabilities of some 230,000 kilograms of cannabis per year when they complete their building projects (should be mid-2019). The wholesale value of cannabis in Canada is $5.20 per gram. If Aphria were to produce 100% of their capabilities and sell at that price, then revenues would be $1.196 billion. I have done a considerable amount of analysis on cannabis stocks. What I have found is that bottom-line margins run fairly consistently at 17%. Given that, net earnings would be $203 million on the $1.196 billion revenue. At a 20-times multiple of the earnings, that values Aphria at $4 billion. The Green Growth offer is for half of that."...... . .My Question is....If Aphrias production cost per gram is under $2 and pot will sell for $5.20/gram. How will these companies like Canopy (production cost per gram $5.50); Tilray production cost per gram $4.75); Cronos production cost per gram $4.25); How can they even EVER turn a profit.


Bullboard Posts